Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer by Philippine Granger Joly de Boissel (21688159)

“…Preclinical positron emission tomography (PET) imaging studies indicate that the radiolabeled [⁶⁴Cu]Cu-NOTA-G1N1 accumulates significantly in breast cancer tumors, highlighting its potential for diagnostic imaging and therapeutic monitoring. …”

Data Sheet 1_Statistics and behavior of clinically significant extra-pulmonary vein atrial fibrillation sources: machine-learning-enhanced electrographic flow mapping in persistent... by Peter Ruppersberg (22123543)

“…Notably, the majority of significant sources were not continuously active; however, when these sources switched “ON,” the spatial variability of AF cycle lengths in the respective atrium decreased by more than 50%, suggesting an entraining effect.…”

CVB3 replication is not influenced in the cells with TRIM56 knockdown. by Yao Wang (102387)

E3 ligase TRIM56 is up-regulated in response to CVB3 infection. by Yao Wang (102387)

TRIM56 promotes the ubiquitination and proteasomal degradation of CVB3 3D. by Yao Wang (102387)

Levels of antioxidant enzymes (A) Catalase, (B) Superoxide dismutase, (C) peroxidase. by Hammad Ismail (4227988)

(A) Time taken to reach platform in hidden trail, (B) Time taken to reach platform in visible trail, (C) Latency time to reach platform zone and (D) Time spent in platform zone in... by Hammad Ismail (4227988)

(A) Mobility distance (B) Explored areas, (C) Immobility time for open field test. by Hammad Ismail (4227988)

(A) Time spent in closed arm, (B) Time spent in open arm, (C) Number of entries in closed arm, (D) Number of entries in open arm, and (E) Latency time to enter open arm for elevate... by Hammad Ismail (4227988)

(A) Time spent in light compartment, (B) Number of transitions between compartments, (C) Number of head pokes to light compartment for light-dark compartment test. by Hammad Ismail (4227988)

(A) Number of crossings, (B) Number of rearings, (C) Latency time for novel object, (D) Familiar object exploration time, (E) Novel object exploration time for novel object recogni... by Hammad Ismail (4227988)

(A) Mobility rate, (B) Explored areas, (5C) Immobility time, (D) Frozen events for hole board test. by Hammad Ismail (4227988)

(A) Immobility time, (B) Frozen events for forced swim test. by Hammad Ismail (4227988)

(A) Serotonin and (B) Dopamine levels in brain tissues. by Hammad Ismail (4227988)

(A) Duration of contacts, (B) Distance covered, (C) Number of interacting contacts, (D) Number of frozen events for social interaction test. by Hammad Ismail (4227988)

ASP protects the AC16 cells from DOX-induced cardiotoxicity via Nrf2 activation. by Xueyang Bai (20550422)

Clinical features. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Study design. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Antimicrobial Treatments. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Routine sporotrichosis laboratory tests. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”